SRX18321563 WZE-E15-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811852 WZE-E15 WZE-E15-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321564 WZE-E15-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811852 WZE-E15 WZE-E15-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321565 STE-E15-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811853 STE-E15 STE-E15-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321566 STE-E15-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811853 STE-E15 STE-E15-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321567 STE-E23-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811854 STE-E23 STE-E23-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321568 STE-E23-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811854 STE-E23 STE-E23-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321569 STE-E23-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811854 STE-E23 STE-E23-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321570 STE-P1-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811855 STE-P1 STE-P1-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321571 STE-P1-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811855 STE-P1 STE-P1-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321572 STE-P1-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811855 STE-P1 STE-P1-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321573 WZE-E15-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811852 WZE-E15 WZE-E15-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321574 WZE-E23-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811856 WZE-E23 WZE-E23-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321575 WZE-E23-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811856 WZE-E23 WZE-E23-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321576 WZE-E23-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811856 WZE-E23 WZE-E23-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321577 WZE-P1-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811857 WZE-P1 WZE-P1-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321578 WZE-P1-2 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811857 WZE-P1 WZE-P1-2 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321579 WZE-P1-3 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811857 WZE-P1 WZE-P1-3 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II SRX18321580 STE-E15-1 SRP408784 bp0 DNA conversion and sequencing: We performed bisulfite modification of 500 ng of DNA from each sample with the EZ DNA methylation kit (Zymo Research, Orange, CA).Each sample was bisulfite modified with the EZ DNA methylation kit (Zymo Research, Orange, CA) using 500 ng DNA.Sequencing and data processing of bisulfite were carried out as described previously. The DNA was fragmented using sonication into 100-500 bp size fragments, followed by blunting and dA addition at the 3'end, followed by adapter ligation.In order to monitor the bisulfite conversion efficiency, the adapter sequence contained multiple methylcytosines.An altered protocol from that previously described was used to convert unmethylated cytosines to uracils following bisulfite treatment.Gel-purified DNA fragments with sizes ranging from 320 to 380 base pairs were sequenced according to manufacturer's instructions. DNA that had been converted was sequenced by Illumina Solexa GA on an Illumina system (Illumina, CA, USA) using 50-bp paired ends. Raw data was processed using the Illumina Pipeline v1.3.1. SRS15811853 STE-E15 STE-E15-1 Bisulfite-Seq GENOMIC RANDOM Illumina Genome Analyzer II